Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Endocrine reviews

• Publication date

  2007-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/ER.2007-0019PMID 17940184
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Androgen deprivation therapy.

  2008cited by this paper
• Selective Role of an NH 2-Terminal WxxLF Motif for Aberrant Androgen Receptor Activation in Androgen Depletion – Independent Prostate Cancer Cells

  2007cited by this paper
• Sexual hormones in human skin.

  2007cited by this paper
• New androgen receptor genomic targets show an interaction with the ETS1 transcription factor

  2007cited by this paper
• New insights for understanding the transcription-coupled repair pathway.

  2007cited by this paper
• Compartmentalization of androgen receptor protein–protein interactions in living cells

  2007cited by this paper
• Androgen induction of the androgen receptor coactivator four and a half LIM domain protein-2: evidence for a role for serum response factor in prostate cancer.

  2007cited by this paper
• Nucleotide excision repair and the ubiquitin proteasome pathway--do all roads lead to Rome?

  2007cited by this paper
• Androgen deprivation increases p300 expression in prostate cancer cells.

  2007cited by this paper
• DJ-1 binds androgen receptor directly and mediates its activity in hormonally treated prostate cancer cells.

  2007cited by this paper
• Proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor enhances androgen receptor functions through LIM-only coactivator, four-and-a-half LIM-only protein 2.

  2007cited by this paper
• The hinge region regulates DNA binding, nuclear translocation, and transactivation of the androgen receptor.

  2007cited by this paper
• Transgelin functions as a suppressor via inhibition of ARA54-enhanced androgen receptor transactivation and prostate cancer cell growth.

  2007cited by this paper
• SOX9 is expressed in normal prostate basal cells and regulates androgen receptor expression in prostate cancer cells.

  2007cited by this paper
• Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression

  2007cited by this paper
• Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation

  2007cited by this paper
• Enhancement of gene transactivation activity of androgen receptor by hepatitis B virus X protein.

  2007cited by this paper
• The role of chromatin during transcription.

  2007influential reference
• Physical and functional interactions of human papillomavirus E2 protein with nuclear receptor coactivators.

  2007cited by this paper
• Regulation of nuclear receptor and coactivator functions by the carboxyl terminus of ubiquitin-conjugating enzyme 9.

  2007cited by this paper
• A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth.

  2007influential reference
• Androgen induction of the androgen receptor co-activator FHL2 : Evidence for a role for serum response factor in prostate cancer

  2007cited by this paper
• Identification of Putative Androgen Receptor Interaction Protein Modules

  2007cited by this paper
• A 90 kDa fragment of filamin A promotes Casodex-induced growth inhibition in Casodex-resistant androgen receptor positive C4-2 prostate cancer cells

  2007cited by this paper
• A novel function of caspase‐8 in the regulation of androgen‐receptor‐driven gene expression

  2007cited by this paper
• Proteasome-Independent Functions of Ubiquitin in Endocytosis and Signaling

  2007cited by this paper
• Suppression of androgen receptor transactivation and prostate cancer cell growth by heterogeneous nuclear ribonucleoprotein A1 via interaction with androgen receptor coregulator ARA54.

  2007cited by this paper
• Essential Role for Co-chaperone Fkbp52 but Not Fkbp51 in Androgen Receptor-mediated Signaling and Physiology*

  2007cited by this paper
• Alien interacts with the human androgen receptor and inhibits prostate cancer cell growth.

  2007cited by this paper
• Coregulators: transducing signal from transcription to alternative splicing.

  2007cited by this paper
• Human papillomavirus E2 protein associates with nuclear receptors to stimulate nuclear receptor- and E2-dependent transcriptional activations in human cervical carcinoma cells.

  2007cited by this paper
• Cell- and gene-specific regulation of primary target genes by the androgen receptor.

  2007cited by this paper
• Hepatitis B virus X protein enhances androgen receptor-responsive gene expression depending on androgen level

  2007cited by this paper
• Selective role of an NH2-terminal WxxLF motif for aberrant androgen receptor activation in androgen depletion independent prostate cancer cells.

  2007cited by this paper
• Epigenetic Information in Chromatin: the Code of Entry for DNA Repair

  2006cited by this paper
• Involvement of arginine methyltransferase CARM1 in androgen receptor function and prostate cancer cell viability

  2006cited by this paper
• The CCAAT enhancer-binding protein-alpha negatively regulates the transactivation of androgen receptor in prostate cancer cells.

  2006cited by this paper
• Male germ cell-associated kinase, a male-specific kinase regulated by androgen, is a coactivator of androgen receptor in prostate cancer cells.

  2006influential reference
• Hic-5/ARA55, a LIM domain-containing nuclear receptor coactivator expressed in prostate stromal cells.

  2006cited by this paper
• Regulation of androgen receptor activity by tyrosine phosphorylation.

  2006cited by this paper
• Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response.

  2006cited by this paper
• Isolation and characterization of a transcriptional cofactor and its novel isoform that bind the deoxyribonucleic acid-binding domain of peroxisome proliferator-activated receptor-gamma.

  2006cited by this paper
• Androgen receptor and prostate apoptosis response factor-4 target the c-FLIP gene to determine survival and apoptosis in the prostate gland.

  2006cited by this paper
• The E3 ubiquitin ligase CHIP binds the androgen receptor in a phosphorylation-dependent manner.

  2006cited by this paper
• Endocytic adaptors: recruiters, coordinators and regulators.

  2006cited by this paper
• JHDM2A, a JmjC-containing H3K9 demethylase, facilitates transcription activation by androgen receptor.

  2006influential reference
• Zimp7 and Zimp10, two novel PIAS-like proteins, function as androgen receptor coregulators

  2006cited by this paper
• Androgen Physiology

  2006influential reference
• Receptor-interacting protein 140 is a repressor of the androgen receptor activity.

  2006cited by this paper
• Isolation and Characterization of a Transcriptional Cofactor and Its Novel Isoform that Bind the Deoxyribonucleic Acid-Binding Domain of Peroxisome Proliferator-Activated Receptor-γ

  2006cited by this paper
• SUMO: regulating the regulator

  2006cited by this paper
• Differential Use of Functional Domains by Coiled-coil Coactivator in Its Synergistic Coactivator Function with β-Catenin or GRIP1*

  2006cited by this paper
• The CCAAT Enhancer-Binding Protein-α Negatively Regulates the Transactivation of Androgen Receptor in Prostate Cancer Cells

  2006cited by this paper
• Ligand-independent Androgen Receptor Activity Is Activation Function-2-independent and Resistant to Antiandrogens in Androgen Refractory Prostate Cancer Cells*

  2006cited by this paper
• The role of the general transcription factor IIF in androgen receptor-dependent transcription.

  2006influential reference
• Dynamic nucleosomes and gene transcription.

  2006influential reference
• The role of forkhead box A2 to restrict androgen-regulated gene expression of lipocalin 5 in the mouse epididymis.

  2006cited by this paper
• Degradation and beyond: Control of androgen receptor activity by the proteasome system

  2006cited by this paper
• Vav3, a Rho GTPase guanine nucleotide exchange factor, increases during progression to androgen independence in prostate cancer cells and potentiates androgen receptor transcriptional activity.

  2006cited by this paper
• Opposite effects of alternative TZF spliced variants on androgen receptor.

  2006cited by this paper
• Androgen receptor regulates nuclear trafficking and nuclear domain residency of corepressor HDAC7 in a ligand-dependent fashion.

  2006cited by this paper
• Keeping transcriptional activators under control.

  2006cited by this paper
• Transcriptional intermediary factor 1alpha mediates physical interaction and functional synergy between the coactivator-associated arginine methyltransferase 1 and glucocorticoid receptor-interacting protein 1 nuclear receptor coactivators.

  2006cited by this paper
• SUMO-3 Enhances Androgen Receptor Transcriptional Activity through a Sumoylation-independent Mechanism in Prostate Cancer Cells*

  2006influential reference
• Makorin RING finger protein 1 (MKRN1) has negative and positive effects on RNA polymerase II-dependent transcription

  2006cited by this paper
• Human PIRH2 Enhances Androgen Receptor Signaling through Inhibition of Histone Deacetylase 1 and Is Overexpressed in Prostate Cancer

  2006influential reference
• Molecular chaperones throughout the life cycle of the androgen receptor.

  2006influential reference
• Vav3 oncogene is overexpressed and regulates cell growth and androgen receptor activity in human prostate cancer.

  2006cited by this paper
• Small carboxyl‐terminal domain phosphatase 2 attenuates androgen‐dependent transcription

  2006cited by this paper
• Testicular zinc finger protein recruits histone deacetylase 2 and suppresses the transactivation function and intranuclear foci formation of agonist-bound androgen receptor competitively with TIF2.

  2006cited by this paper
• Histone acetyltransferase HBO1 inhibits NF-kappaB activity by coactivator sequestration.

  2006cited by this paper
• The human androgen receptor AF1 transactivation domain: interactions with transcription factor IIF and molten-globule-like structural characteristics.

  2006cited by this paper
• Unraveling androgen receptor interactomes by an array-based method: discovery of proto-oncoprotein c-Rel as a negative regulator of androgen receptor.

  2006cited by this paper
• c-Jun enhancement of androgen receptor transactivation is associated with prostate cancer cell proliferation

  2006cited by this paper
• Multifunction steroid receptor coactivator, E6-associated protein, is involved in development of the prostate gland.

  2006cited by this paper
• FOXO1A is a candidate for the 13q14 tumor suppressor gene inhibiting androgen receptor signaling in prostate cancer.

  2006cited by this paper
• Expression and function of human steroid receptor RNA activator in prostate cancer cells: role of endogenous hSRA protein in androgen receptor-mediated transcription

  2006cited by this paper
• Huntingtin-associated protein 1 (HAP1) interacts with androgen receptor (AR) and suppresses SBMA-mutant-AR-induced apoptosis.

  2006cited by this paper
• Expression and role of Foxa proteins in prostate cancer

  2006cited by this paper
• Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation

  2006cited by this paper
• Biochemical characterization of androgen receptor-interacting protein 4.

  2006cited by this paper
• Hormonal Control of Androgen Receptor Function through SIRT1

  2006influential reference
• Identification of the functional domains of ANT-1, a novel coactivator of the androgen receptor.

  2006cited by this paper
• The multifunctional roles of the four-and-a-half-LIM only protein FHL2

  2006cited by this paper
• Actin in transcription and transcription regulation.

  2006cited by this paper
• Receptor for activated C kinase 1 (RACK1) and Src regulate the tyrosine phosphorylation and function of the androgen receptor.

  2006cited by this paper
• The androgen receptor DNA-binding domain determines androgen selectivity of transcriptional response.

  2006influential reference
• Membrane microdomains, caveolae, and caveolar endocytosis of sphingolipids (Review)

  2006cited by this paper
• Androgens modulate expression of transcription intermediary factor 2, an androgen receptor coactivator whose expression level correlates with early biochemical recurrence in prostate cancer.

  2006cited by this paper
• Macrophage/cancer cell interactions mediate hormone resistance by a nuclear receptor derepression pathway.

  2006cited by this paper
• Histone H3 Lysine 9 Methyltransferase G9a Is a Transcriptional Coactivator for Nuclear Receptors*

  2006cited by this paper
• ERK8 Down-regulates Transactivation of the Glucocorticoid Receptor through Hic-5*

  2006cited by this paper
• Cyclin G‐associated kinase: A novel androgen receptor‐interacting transcriptional coactivator that is overexpressed in hormone refractory prostate cancer

  2006cited by this paper
• The ubiquitin-specific protease USP10 modulates androgen receptor function.

  2005cited by this paper
• Cyclin D1 binding to the androgen receptor (AR) NH2-terminal domain inhibits activation function 2 association and reveals dual roles for AR corepression.

  2005cited by this paper
• Modulation of the expression and transactivation of androgen receptor by the basic helix-loop-helix transcription factor Pod-1 through recruitment of histone deacetylase 1.

  2005cited by this paper
• Androgen receptor-cofactor interactions as targets for new drug discovery.

  2005cited by this paper
• The Type I Hsp40 Zinc Finger-like Region Is Required for Hsp70 to Capture Non-native Polypeptides from Ydj1*

  2005cited by this paper
• Spatial and temporal recruitment of androgen receptor and its coactivators involves chromosomal looping and polymerase tracking.

  2005cited by this paper
• 9-cis-retinoic acid inhibits androgen receptor activity through activation of retinoid X receptor.

  2005cited by this paper

• Emerging roles of PARP-1 driven dual inhibitors in cancer therapy: SAR-guided strategies and synthetic lethality.

  2026cites this paper
• Comprehensive androgen-dependent transcriptome analysis in human genital tissue

  2025cites this paper
• Evolving roles for the androgen receptor and its protein interactome in castration-resistant prostate cancer

  2025influential citation
• Coregulators determine androgen receptor activity in prostate cancer

  2025cites this paper
• Artificial induction of female-to-male sex change in the leopard coral grouper Plectropomus leopardus via intraperitoneal administration of 17α-methyltestosterone and letrozole

  2025cites this paper
• Androgens as the “old age stick” in skeletal muscle

  2025cites this paper
• Disrupting the interaction between androgen receptor and its coregulator WDR77 delays the growth of treatment-resistant prostate cancer.

  2025cites this paper
• Preclinical assessment of the selective androgen receptor modulator RAD140 to increase muscle mass and bone mineral density

  2025cites this paper
• A novel peptide explicitly induces prostate cancer cell death by destabilizing AR and inhibiting AR-mediated transcription.

  2025cites this paper
• Testosterone and Androgen Receptor in Cancers with Significant Sex Dimorphism in Incidence Rates and Survival

  2025cites this paper
• Rho Small GTPase Family in Androgen-Regulated Prostate Cancer Progression and Metastasis

  2025cites this paper
• Extracellular vesicles-mediated delivery of CRISPR machinery silences androgen receptor in castration-resistant prostate cancer cells.

  2025cites this paper
• Polycyclic Aromatic Hydrocarbons in Marine Environments Affect Fish Reproduction—A Critical Review

  2025cites this paper
• The landscape of N6-methyladenosine in localized primary prostate cancer

  2025cites this paper
• Poly(ADP-ribose) polymerase-1 (PARP1)-based dual inhibitors targeting cancer synthetic lethality (2022-present): advances and perspectives.

  2025cites this paper
• AOP report: Adverse Outcome Pathway Network for Developmental Androgen Signalling-Inhibition Leading to Short Anogenital Distance in Male Offspring.

  2025cites this paper
• Mechanisms of bisphenol A and its analogs as endocrine disruptors via nuclear receptors and related signaling pathways

  2025cites this paper
• BAP18, as a corepressor of AR together with the SIN3A/HDAC complex, promotes AR-positive triple-negative breast cancer progression

  2025cites this paper
• Precision Medicine in Prostate Cancer: The Role of Molecular Diagnostics and Targeted Therapies

  2025cites this paper
• Kobochromone A, a polyphenol in Carex kobomugi, suppresses androgen signaling induced by 11-oxygenated androgens and enhances the efficacy of AKT inhibitors in triple-negative breast cancer cells.

  2025cites this paper
• Androgen Receptors in Human Breast Cancer and Female Canine Mammary Tumors

  2025cites this paper
• Restraining SRD5A1 combined with BRD4 inhibitor delaying prostate cancer progression by decreasing AR expression.

  2025cites this paper
• Transcriptional and epigenetic reprogramming, lineage plasticity and therapy resistance in prostate cancer.

  2025cites this paper
• Androgen receptors and Zinc finger (ZNF) Transcription Factors’ Interplay and Their miRNA Regulation in Prostate Cancer Prognosis

  2025cites this paper
• ZFHX3 is integral to androgen/AR signaling involving protein association with AR in prostate cancer cells

  2025cites this paper
• Molecular Profile and Clinical Associations of Androgen Receptor Coactivators and Structural Genes in Benign Prostatic Hyperplasia and Metabolic Syndrome

  2025cites this paper
• Simultaneous inhibition of TRIM24 and TRIM28 sensitises prostate cancer cells to antiandrogen therapy, decreasing VEGF signalling and angiogenesis

  2025cites this paper
• Hallmarks of sex bias in immuno-oncology: mechanisms and therapeutic implications

  2024cites this paper
• Molecular insights into Sertoli cell function: how do metabolic disorders in childhood and adolescence affect spermatogonial fate?

  2024cites this paper
• Secondary Cancer after Androgen Deprivation Therapy in Prostate Cancer: A Nationwide Study

  2024cites this paper
• How to drug a cloud? Targeting intrinsically disordered proteins.

  2024cites this paper
• The Effects of Neuroactive Steroids on Myelin in Health and Disease

  2024cites this paper
• Androgen deficiency is associated with a better prognosis in glioblastoma

  2024cites this paper
• RISING STARS: Androgens and immune cell function

  2024cites this paper
• Dose-Dependent Transcriptional Response to Ionizing Radiation Is Orchestrated with DNA Repair within the Nuclear Space

  2024cites this paper
• Discovery of Novel Anti‐Resistance AR Antagonists Guided by Funnel Metadynamics Simulation

  2024cites this paper
• CAGn Polymorphic Locus of Androgen Receptor (AR) Gene in Russian Infertile and Fertile Men

  2024cites this paper
• Androgen receptor signalling in non-prostatic malignancies: challenges and opportunities

  2024cites this paper
• Harnessing machine learning and multi-omics to explore tumor evolutionary characteristics and the role of AMOTL1 in prostate cancer.

  2024cites this paper
• SWI/SNF chromatin remodelers in prostate cancer progression

  2024cites this paper
• Epigenetic regulation of nuclear receptors: Implications for endocrine-related diseases and therapeutic strategies

  2024cites this paper
• QSPRmodeler - An open source application for molecular predictive analytics

  2024cites this paper
• Androgen receptor cofactors: A potential role in understanding prostate cancer.

  2024cites this paper
• Diverse phenotypes and fertility outcomes of patients with androgen insensitivity syndrome in a Chinese family harboring identical AR gene variant

  2024cites this paper
• Friend or foe? Deciphering androgen receptor action to improve bipolar androgen therapy for prostate cancer.

  2024cites this paper
• Sexual Dimorphism and Hypothalamic Astrocytes: Focus on Glioprotection

  2024cites this paper
• Influence of radical prostatectomy on miRNA dynamics in urine extracellular vesicles.

  2024cites this paper
• Inhibitors of the transactivation domain of androgen receptor as a therapy for prostate cancer.

  2024cites this paper
• Exploring androgen receptor signaling pathway in prostate cancer: A path to new discoveries

  2024cites this paper
• Small molecule agents against alopecia: Potential targets and related pathways.

  2024cites this paper
• Phase Separation Mediated Sub-Nuclear Compartmentalization of Androgen Receptors

  2024cites this paper
• Can Prostate Cancer Patients be Prescribed Chinese Herbal Medicine? A Review of its Potential Modulatory Effects on the Androgen Receptor

  2024cites this paper
• N-terminal domain of androgen receptor is a major therapeutic barrier and potential pharmacological target for treating castration resistant prostate cancer: a comprehensive review

  2024cites this paper
• Artepillin C overcomes apalutamide resistance through blocking androgen signaling in prostate cancer cells.

  2023cites this paper
• Mechanisms of Prostate Cancer Cells Survival and Their Therapeutic Targeting

  2023cites this paper
• Heterozygous Cc2d1a mice show sex-dependent changes in the Beclin-1/p62 ratio with impaired prefrontal cortex and hippocampal autophagy.

  2023cites this paper
• Incidence of Prostate Cancer in Transgender Women Undergoing Androgen Deprivation Therapy: A Review

  2023cites this paper
• Dissecting the effects of androgen deprivation therapy on cadherin switching in advanced prostate cancer: A molecular perspective

  2023cites this paper
• Determination of the androgen receptor status of disseminated tumor cells in primary breast cancer patients

  2023cites this paper
• Organizational Effects of Gonadal Hormones on Human Sexual Orientation

  2023cites this paper
• CYP19A1 is downregulated by BRD4 and suppresses castration-resistant prostate cancer cell invasion and proliferation by decreasing AR expression.

  2023cites this paper
• International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily—Update 2023

  2023cites this paper
• Targeting the Androgen Signaling Axis in Prostate Cancer.

  2023cites this paper
• Evaluation of androgen receptor markers in erectile dysfunction

  2023cites this paper
• Palmitoyl acyltransferase ZDHHC7 inhibits androgen receptor and suppresses prostate cancer

  2023cites this paper
• Targeting sex steroid biosynthesis for breast and prostate cancer therapy

  2023cites this paper
• Potential roles of FGF5 as a candidate therapeutic target in prostate cancer.

  2023cites this paper
• PROSTATE CANCER AND BONE: CLINICAL PRESENTATION AND MOLECULAR MECHANISMS.

  2023cites this paper
• AR and PI3K/AKT in Prostate Cancer: A Tale of Two Interconnected Pathways

  2023cites this paper
• Influence of androgens on the innate immune system

  2023cites this paper
• Advances in PARP Inhibitors for Prostate Cancer

  2023cites this paper
• WTAP boosts lipid oxidation and induces diabetic cardiac fibrosis by enhancing AR methylation

  2023cites this paper
• Alpha Thalassemia/Intellectual Disability Syndrome X-Linked Expression Varies Significantly between Androgen Receptor-Positive and Androgen Receptor-Negative Prostatic Adenocarcinoma: Relation to Epidermal Growth Factor Receptor Expression and Clinicopathological Factors

  2023influential citation
• Androgen Receptor-Mediated Transcription in Prostate Cancer

  2022cites this paper
• CYP19A1 Is Regulated by BRD4 and Suppresses Castration-resistant Prostate Cancer Cell Invasion and Proliferation by Decreasing AR Expression

  2022cites this paper
• Analyzing the Androgen Receptor Interactome in Prostate Cancer: Implications for Therapeutic Intervention

  2022influential citation
• Receptor-Mediated Redox Imbalance: An Emerging Clinical Avenue against Aggressive Cancers

  2022cites this paper
• In Vivo Models for Prostate Cancer Research

  2022cites this paper
• Role of CAG and GGC Polymorphism of the Androgen Receptor Gene in Male Fertility

  2022cites this paper
• Hormonal therapies up-regulate MANF and overcome female susceptibility to immune checkpoint inhibitor myocarditis

  2022cites this paper
• Androgen Metabolism and Response in Prostate Cancer Anti-Androgen Therapy Resistance

  2022cites this paper
• Androgen Receptor Signaling Inhibition in Advanced Castration Resistance Prostate Cancer: What Is Expected for the Near Future?

  2022cites this paper
• Epigenetic Coregulation of Androgen Receptor Signaling.

  2022cites this paper
• Androgen Receptor Gene CAG Repeat Length Varies and Affects Semen Quality in an Ethnic-Specific Fashion in Young Men from Russia

  2022cites this paper
• AR-regulated ZIC5 contributes to the aggressiveness of prostate cancer

  2022cites this paper
• Non-canonical androgen signaling pathways and implications in prostate cancer.

  2022cites this paper
• Enzalutamide Induces Apoptotic Insults to Human Drug-Resistant and -Sensitive Glioblastoma Cells via an Intrinsic Bax-Mitochondrion-Cytochrome C Caspase Cascade Activation Pathway

  2022cites this paper
• The androgen receptor couples promoter recruitment of RNA processing factors to regulation of alternative polyadenylation at the 3' end of transcripts

  2022cites this paper
• Resistance to prostate cancer treatments

  2022cites this paper
• Androgen Receptor Signaling is Similar in Human Corpus Cavernosum in Men with Different Serum Testosterone Levels.

  2022cites this paper
• Molecular Regulation of Androgen Receptors in Major Female Reproductive System Cancers

  2022cites this paper
• TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2‐mediated degradation

  2022cites this paper
• AOP Key Event Relationship Report: Linking decreased androgen receptor activation with decreased granulosa cell proliferation of gonadotropin-independent follicles.

  2022cites this paper
• Advances in the Current Understanding of the Mechanisms Governing the Acquisition of Castration-Resistant Prostate Cancer

  2022cites this paper
• GENETIC VARIABILITY IN THE PRNCR1 GENE AMONG A SAMPLE OF IRAQI PROSTATE CANCER PATIENTS

  2022cites this paper
• AOP key event relationship report: Linking androgen receptor antagonism with nipple retention

  2022cites this paper
• The DNA/RNA helicase DHX9 contributes to the transcriptional program of the androgen receptor in prostate cancer

  2022cites this paper
• Nuclear hormone receptors in demyelinating diseases

  2022cites this paper
• A classification of genes involved in normal and delayed male puberty

  2022cites this paper
• Basics of androgen synthesis and action.

  2022cites this paper